Hetero
Lakshmana Chari Akarapu is an accomplished professional in the pharmaceutical industry with extensive experience in operations management. Currently serving as Vice President of Operations at Hetero, Lakshmana oversees all overseas formulation plants since May 2024. Previous roles include Associate Vice President (Plant Head) at Eugia Pharma Specialities Ltd and Senior GM Operations (Plant Head) at Aurobindo Pharma Limited. Lakshmana has held key positions focusing on plant operations, production, and technology transfer across various companies, including Aurobindo Pharma and Alembic Pharmaceuticals. Educational qualifications include a Bachelor of Pharmacy from Kakatiya University and an ongoing MBA in Operations Management and Supervision from Amity University.
This person is not in the org chart
This person is not in any offices
Hetero
4 followers
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc. Hetero has a strong global presence in over 145+ countries and focusses on making affordable medicines accessible to patients worldwide.